Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30013942HIVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TVIS30074295HIVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TVIS30048296HIVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TVIS30048297HIVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TVIS20007387HPVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TVIS20007388HPVENSG00000105639.21protein_codingJAK3YesNo3718P52333
TCGA Plot Options
Drug Information
GeneJAK3
DrugBank IDDB15035
Drug NameZanubrutinib
Target IDBE0003493
UniProt IDP52333
Regulation Typeinhibitor
PubMed IDs31381333
CitationsGuo Y, Liu Y, Hu N, Yu D, Zhou C, Shi G, Zhang B, Wei M, Liu J, Luo L, Tang Z, Song H, Guo Y, Liu X, Su D, Zhang S, Song X, Zhou X, Hong Y, Chen S, Cheng Z, Young S, Wei Q, Wang H, Wang Q, Lv L, Wang F, Xu H, Sun H, Xing H, Li N, Zhang W, Wang Z, Liu G, Sun Z, Zhou D, Li W, Liu L, Wang L, Wang Z: Discovery of Zanubrutinib (BGB-3111), a Novel, Potent, and Selective Covalent Inhibitor of Bruton's Tyrosine Kinase. J Med Chem. 2019 Sep 12;62(17):7923-7940. doi: 10.1021/acs.jmedchem.9b00687. Epub 2019 Aug 19.
GroupsApproved; Investigational
Direct ClassificationDiphenylethers
SMILESNC(=O)C1=C2NCC[C@@H](C3CCN(CC3)C(=O)C=C)N2N=C1C1=CC=C(OC2=CC=CC=C2)C=C1
Pathways
PharmGKB
ChEMBLCHEMBL3936761